These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36006487)

  • 1. Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort study.
    Boswell L; Serés-Noriega T; Mesa A; Perea V; Pané A; Viñals C; Blanco J; Giménez M; Vinagre I; Esmatjes E; Conget I; Amor AJ
    Acta Diabetol; 2022 Dec; 59(12):1563-1574. PubMed ID: 36006487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit.
    Amor AJ; Ortega E; Giménez M; Cofán M; Blanco J; Pané A; Boswell L; Vinagre I; Esmatjes E; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):512-519. PubMed ID: 31000451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk.
    Serés-Noriega T; Giménez M; Perea V; Boswell L; Viñals C; Blanco J; Vinagre I; Pané A; Esmatjes E; Conget I; Amor AJ
    Diabetes Care; 2022 Oct; 45(10):2412-2421. PubMed ID: 35944257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; García-Ruiz JM; Mendiguren J; Bueno H; Pocock S; Ibáñez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2017 Dec; 70(24):2979-2991. PubMed ID: 29241485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetes.
    Lan NSR; Bell DA; Watts GF; Fegan PG
    Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):103-112. PubMed ID: 36472130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
    Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
    Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid management for cardiovascular risk reduction in type 1 diabetes.
    Tell S; Nadeau KJ; Eckel RH
    Curr Opin Endocrinol Diabetes Obes; 2020 Aug; 27(4):207-214. PubMed ID: 32618632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia Is Associated With Increased Preclinical Carotid Atherosclerosis in Women With Type 1 Diabetes.
    Amor AJ; Vinagre I; Valverde M; Pané A; Urquizu X; Meler E; López E; Quirós C; Giménez M; Codina L; Conget I; Barahona MJ; Perea V
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31529047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.
    Yun SJ; Jeong IK; Cha JH; Lee J; Cho HC; Choi SH; Chun S; Jeon HJ; Kang HC; Kim SS; Ko SH; Koh G; Kwon SK; Lee JH; Moon MK; Noh J; Park CY; Kim S
    Diabetes Metab J; 2021 May; 46(3):464-475. PubMed ID: 35235742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.
    Leiter LA; Cariou B; Müller-Wieland D; Colhoun HM; Del Prato S; Tinahones FJ; Ray KK; Bujas-Bobanovic M; Domenger C; Mandel J; Samuel R; Henry RR
    Diabetes Obes Metab; 2017 Dec; 19(12):1781-1792. PubMed ID: 28905478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
    Blom DJ; Ranjith N; Joshi P; Naidoo P; van Tonder A; Musa MG; Joshi S; Leisegang R; Trokis JS; Makan H; Raal FJ
    Cardiovasc J Afr; 2020; 31(5):245-251. PubMed ID: 33151240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
    Marrett E; Zhao C; Zhang NJ; Zhang Q; Ramey DR; Tomassini JE; Tershakovec AM; Neff DR
    Vasc Health Risk Manag; 2014; 10():237-46. PubMed ID: 24851051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of fatty acid intake are independently associated with preclinical atherosclerosis in individuals with type 1 diabetes.
    Mesa A; Cofán M; Esmatjes E; Perea V; Boswell L; Giménez M; Sala-Vila A; Vinagre I; Viñals C; Chiva-Blanch G; Serés-Noriega T; Blanco J; Conget I; Ortega E; Amor AJ
    Eur J Nutr; 2021 Dec; 60(8):4595-4605. PubMed ID: 34152460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease.
    Cannon CP; Khan I; Klimchak AC; Reynolds MR; Sanchez RJ; Sasiela WJ
    JAMA Cardiol; 2017 Sep; 2(9):959-966. PubMed ID: 28768335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Breuker C; Clement F; Mura T; Macioce V; Castet-Nicolas A; Audurier Y; Boegner C; Morcrette E; Jalabert A; Villiet M; Avignon A; Sultan A
    Int J Cardiol; 2018 Oct; 268():195-199. PubMed ID: 30041785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.